This preclinical study used human lens epithelial cells and mouse lenses to show that microRNA-34a (MIR34A) directly targets and suppresses hexokinase 1 (HK1), leading to increased apoptosis and lens opacification through the HK1/caspase 3 pathway.
Aging (Albany NY) · 7 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical study used human lens epithelial cells and mouse lenses to show that microRNA-34a (MIR34A) directly targets and suppresses hexokinase 1 (HK1), leading to increased apoptosis and lens opacification through the HK1/caspase 3 pathway.
This preclinical study investigated the role of microRNA-34a (MIR34A) and hexokinase 1 (HK1) in cataract development. Using the human lens epithelial cell line SRA01/04 and mouse lenses, the researchers demonstrated that MIR34A directly targets and suppresses HK1 expression. In vitro, upregulation of MIR34A or downregulation of HK1 inhibited cell proliferation, induced apoptosis, and increased caspase 3 activity. In a mouse model, overexpression of Mir34a or Hk1 downregulation accelerated lens opacification. The authors conclude that MIR34A modulates lens epithelial cell apoptosis and cataract formation via the HK1/caspase 3 signaling pathway.